Case Control Study
Copyright ©The Author(s) 2023.
World J Clin Cases. May 16, 2023; 11(14): 3158-3166
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3158
Figure 1
Figure 1 Receiver operating characteristic curve of serum ubiquitin carboxy-terminal hydrolase L1 and glial fibrillary acidic protein levels for predicting postoperative recurrence of glioma. UCH-L1: Ubiquitin carboxy-terminal hydrolase L1; GFAP: Glial fibrillary acidic protein.